Not logged in Post Hoc Subgroup Analysis of Clinical Outcomes in Patients With High-Risk Metastatic Hormone-Naïve Prostate Cancer: Results From a 3-Year Interim Analysis of the J-ROCK Study Mizokami, Atsushi; Matsumoto, Rikiya; Miyake, Hideaki; Uemura, Hiroji; Uemura, Hirotsugu; Kawakami, Satoru; Nakamura, Kazuyoshi; Shigekatsu Maekawa; Tsuchiya, Hiroaki; Okazaki, Sachie; Adachi, Eri; Yano, Ryo; Tajima, Yohei; Fujimoto, Kiyohide; Matsuyama, Hideyasu Share Save
Share Save
Share Save
Share Save
Longitudinal assessment of bone mineral density in prostate cancer patients: comparing metastatic and non-metastatic regions Hara, Takuto; Nishimoto, Hanako; Terakawa, Tomoaki; Okamura, Yasuyoshi; Bando, Yukari; Ueki, Hideto; Suzuki, Kotaro; Hyodo, Yoji; Teishima, Jun; Chiba, Koji; Kuroda, Ryosuke; Miyake, Hideaki Share Save
Safety and efficacy of oral cancer vaccine B440 in patients with PD-1/PD-L1 inhibitor-resistant advanced urothelial cancer: a study protocol for a phase 1 multicenter, open-label, single-arm clinical trial Furukawa, Junya; Kakei, Yasumasa; Murakami, Sae; Kita, Hiroshi; Ueki, Hideto; Hara, Takuto; Teishima, Jun; Hinata, Nobuyuki; Miyake, Hideaki; Fujisawa, Masato; Shirakawa, Toshiro Share Save
Clinical Outcomes of Patients with High-risk Metastatic Hormone-naive Prostate Cancer: A 3-year Interim Analysis of the Observational J-ROCK Study Miyake, Hideaki; Matsumoto, Rikiya; Fujimoto, Kiyohide; Mizokami, Atsushi; Uemura, Hirotsugu; Kamoto, Toshiyuki; Kawakami, Satoru; Nakamura, Kazuyoshi; Maekawa, Shigekatsu; Shibayama, Kazuhiro; Watanabe, Aki; Ito, Miku; Tajima, Yohei; Matsuyama, Hideyasu; Uemura, Hiroji Share Save
Effect of HLA Genotype on Anti-PD-1 Antibody Treatment for Advanced Renal Cell Carcinoma in the SNiP-RCC Study Tanegashima, Tokiyoshi; Shiota, Masaki; Fujiyama, Nobuhiro; Narita, Shintaro; Habuchi, Tomonori; Fukuchi, Genshiro; Takamatsu, Dai; Oda, Yoshinao; Miyake, Hideaki; Takahashi, Masayuki; Oya, Mototsugu; Tsuchiya, Norihiko; Masumori, Naoya; Matsuyama, Hideyasu; Obara, Wataru; Shinohara, Nobuo; Fujimoto, Kiyohide; Nozawa, Masahiro; Ohba, Kojiro; Ohyama, Chikara; Hashine, Katsuyoshi; Akamatsu, Shusuke; Kamba, Tomomi; Mita, Koji; Gotoh, Momokazu; Tatarano, Shuichi; Fujisawa, Masato; Tomita, Yoshihiko; Mukai, Shoichiro; Ito, Keiichi; Tokunaga, Shoji; Eto, Masatoshi Share Save
Share Save
Share Save
TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor-Naïve Locally Advanced or Metastatic Urothelial Carcinoma Nishiyama, Hiroyuki; Yonese, Junji; Kawahara, Takashi; Matsumoto, Ryuji; Miyake, Hideaki; Matsubara, Nobuaki; Uemura, Hiroji; Eto, Masatoshi; Azuma, Haruhito; Obara, Wataru; Terai, Akito; Fukasawa, Satoshi; Suekane, Shigetaka Share Save
Efficacy of avelumab plus axitinib versus sunitinib by numbers of IMDC risk factors and target tumor sites at baseline in advanced renal cell carcinoma: long-term follow-up results from JAVELIN Renal 101 Tomita, Y.; Motzer, R. J.; Choueiri, T. K.; Rini, B. I.; Miyake, H.; Oya, M.; Albiges, L.; Aizawa, M.; Umeyama, Y.; Wang, J.; di Pietro, A.; Schmidinger, M. Share Save
Efficacy and safety of second-line cabozantinib after immuno-oncology combination therapy for advanced renal cell carcinoma: Japanese multicenter retrospective study Sazuka, Tomokazu; Matsushita, Yuto; Sato, Hiroaki; Osawa, Takahiro; Hinata, Nobuyuki; Hatakeyama, Shingo; Numakura, Kazuyuki; Ueda, Kosuke; Kimura, Takahiro; Takahashi, Masayuki; Tanaka, Hajime; Kawasaki, Yoshihide; Kurahashi, Toshifumi; Kato, Takuma; Fujita, Kazutoshi; Miyake, Makito; Kojima, Takahiro; Kitamura, Hiroshi; Miyake, Hideaki; Ichikawa, Tomohiko Share Save
Prostate-specific antigen response to different real-world treatments in high-risk metastatic hormone-naive prostate cancer in J-ROCK registry study Mizokami, A.; Matsumoto, R.; Fujimoto, K.; Miyake, H.; Uemura, H.; Uemura, H.; Kawakami, S.; Nakamura, K.; Maekawa, S.; Shibayama, K.; Tajima, Y.; Kamoto, T.; Matsuyama, H. Share Save
Share Save
Share Save
Share Save
Novel nomogram developed for determining suitability of metastatic castration-resistant prostate cancer patients to receive maximum benefit from radium-223 dichloride treatment-Japanese Ra-223 Therapy in Prostate Cancer using Bone Scan Index (J-RAP-BSI) Trial Kitajima, Kazuhiro; Igeta, Masataka; Kuyama, Junpei; Kawahara, Takashi; Suga, Tsuyoshi; Otani, Tomoaki; Sugawara, Shigeyasu; Kono, Yumiko; Tamaki, Yukihisa; Seko-Nitta, Ayumi; Ishiwata, Yoshinobu; Ito, Kimiteru; Toriihara, Akira; Watanabe, Shiro; Hosono, Makoto; Miyake, Hideaki; Yamamoto, Shingo; Narita, Mitsuhiro; Daimon, Takashi; Yamakado, Koichiro Share Save
Development of a Simple and Objective Prognostication Model for Patients with Advanced Solid Malignant Tumors Treated with Immune Checkpoint Inhibitors: A Pan-Cancer Analysis Sano, Asuka; Inoue, Yusuke; Kikuchi, Hirotoshi; Fukuchi, Kensuke; Funai, Kazuhito; Imai, Atsushi; Matsushita, Yuto; Tamura, Keita; Kitagawa, Masatoshi; Miyake, Hideaki Share Save
Efficacy and safety of avelumab plus axitinib in elderly patients with advanced renal cell carcinoma: extended follow-up results from JAVELIN Renal 101 Tomita, Y.; Motzer, R. J.; Choueiri, T. K.; Rini, B., I; Miyake, H.; Uemura, H.; Albiges, L.; Fujii, Y.; Umeyama, Y.; Wang, J.; Mariani, M.; Schmidinger, M. Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
